Abstract:Objective: To investigate the effects of primary preventive treatment under endoscope for esophageal and gastric varices on bleeding rate and its relevant factors. Methods: 127 cases with liver cirrhosis accompanied with esophageal and gastric varices without bleeding history were included in the endoscopic and non-endoscopic treatment group, respectively. Informed consent was obtained from both groups. Gastric varices (Lgf) and esophageal varices (Leg) were diagnosed according to LDRf classification criteria, and the corresponding treatment scheme was selected according to the recommended principle of this method.The incidence rate of bleeding from ruptured esophageal varices were observed at 3, 6 months, and 1, and 2 years in the treated and the untreated group, and the patients with different Child-Pugh scores were followed-up for 2 years. Gender, age, etiology, varicose degree, Child-Pugh grade, platelet count, prothrombin activity, portal vein thrombosis, collateral circulation, portal vein width and other factors affecting the bleeding rate were assessed. Measurement data were described as mean ± standard deviation (x¯±s), and qualitative data of categorical variables were expressed as percentage (%), and χ2 test was used. Results: 127 cases were followed up for 2 years. There were 55 cases in the endoscopic treatment group (18 cases underwent band ligation, 2 cases underwent band ligation combined with tissue adhesive embolization, 28 cases underwent sclerotherapy, and 7 cases underwent sclerotherapy combined with tissue adhesive embolization). Recurrent bleeding and hemorrhage was occurred in 5 (9.1%) and 28 cases (38.9%), respectively (P<0.05). In addition, there were 72 cases in the untreated group (P<0.05). Severe varicose veins proportions in treated and untreated group were 91.1% and 85.1%, respectively (P>0.05). There was no statistically significant difference in liver cirrhosis-related medication and β-blocker therapy between the treated and untreated group (P>0.05). There was no statistically significant difference in the bleeding rate between the different treated groups (P>0.05). The bleeding rates at 3, 6 months, 1, and 2 years in endoscopic treated and untreated group were 2.00% vs. 2.59% (P>0.05), 2.30% vs. 5.88% (P>0.05), 3.10% vs. 7.55% (P>0.05) and 4.00% vs. 21.62% (P<0.05), respectively. All patients with Child-Pugh grade A, B and C in the treated and the untreated group were followed-up for 2 years, and the bleeding rates were 1.8% vs. 8.1% (P<0.05), 1.1% vs. 9.4% (P<0.05) and 9.1% vs. 10.1% (P>0.05), respectively. There were statistically significant differences in the rupture and bleeding of esophageal and gastric varices, varices degree, Child-Pugh grade and presence or absence of thrombosis formation in portal vein (P<0.05); however, no statistically significant differences in gender, age, etiology, platelet count, prothrombin activity, collateral circulation and portal vein width (P>0.05). There was no intraoperative bleeding and postoperative related serious complications in the treated group. Conclusion: The risk of initial episodes of bleeding from esophageal and gastric varices is significantly correlated with the varices degree, Child-Pugh grade, and portal vein thrombosis. Primary preventive treatment under endoscope is safe and effective for reducing the long-term variceal bleeding risk from esophageal and gastric varices.

The short-term effect and saftety analysis of endoscopic esophageal variceal ligation

Esophageal Variceal Ligation Monotherapy Versus Combined Ligation and Sclerotherapy for the Treatment of Esophageal Varices.

Clinical Analysis of Endoscopic Esophageal Variceal Ligation in 24 Patients

An Evaluation of Emergent Endoscopic Variceal Ligation in Treatment of Cirrhotic Patients with Acute Esophageal Variceal Bleeding

Risk Factors for Predicting Early Variceal Rebleeding after Endoscopic Variceal Ligation

THE CLINICAL EFFECT ON ENDOSCOPIC VARICEAL LIGATION FOR ESOPHAGEAL VARICES

Clinical Study of Endoscopic Variceal Ligation Prevention Treatment to Cirrhosis with Sever Varices

[Effects of primary preventive treatment under endoscope for esophageal and gastric varices on bleeding rate and its relevant factors]

Study on Efficacy of Endoscopic Ligation Therapy for Esophageal Varices and Risk Factors for Postoperative Rebleeding

Clinical therapeutic effects of endoscopic drug therapy for treatment of patients with acute esophageal and gastric variceal bleeding

Analysis of Efficacy of Endoscopic Variceal Ligation in the Treatment of Bleeding Esophageal Varices Caused by Cavernous Transformation of Portal Vein

Influencing factors for the clinical effect of emergency endoscopic therapy in treatment of acute-on-chronic liver failure with gastroesophageal variceal bleeding

Clinical evaluation of different modalities in emergency endoscopic treatment of esophageal variceal bleeding

A retrospective analysis of the efficacy of endoscopic variceal ligation versus endoscopic tissue adhesive injection in the treatment of esophagogastric variceal bleeding

The impact of portal vein thrombosis on the long-term efficacy of endoscopic treatment for acute esophageal and gastric variceal bleeding patients

Efficacy of endoscopic variceal ligation combined with partial splenic embolization for the treatment of esophageal varices

Long-term Effect of Endoscopic Ligation for Bleeding Esophageal Varices

The clinical study of selective paraesophagogastric devascularization and splenectomy plus distal esophageal transection and reanastomosis with stapler for treatment of esophageal variceal bleeding due to portal hypertension

Portal Vein Thrombosis Can Aggravate Esophageal Variceal Bleeding After Endoscopic Variceal Ligation

Clinical effect of emergency gastroscopic ligation,sclerotherapy,and tissue adhesive injection in treatment of esopha-gogastric junctional variceal bleeding

Application of Laparoscopic Ligation of Left Gastric Vessels and Main Splenic Artery for Severe Cirrhosis with Portal Hypertension